Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study

被引：39
|
作者：
Uchida, H. [1 ]
Kamata, M. [1 ]
Mizukawa, I. [1 ]
Watanabe, A. [1 ]
Agematsu, A. [1 ]
Nagata, M. [1 ]
Fukaya, S. [1 ]
Hayashi, K. [1 ]
Fukuyasu, A. [1 ]
Tanaka, T. [1 ]
Ishikawa, T. [1 ]
Ohnishi, T. [1 ]
Tada, Y. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 05期
关键词：
PLACEBO;
D O I：
10.1111/bjd.18163
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：1083 / 1085
页数：3
相关论文
共 50 条
  • [31] One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate- to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis
    Lee, Hanjae
    Kim, Bo Ri
    Kim, Kyu Han
    Lee, Dong Hun
    Na, Jung Im
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (01) : 117 - 122
  • [32] Management of atopic dermatitis in patients non-responsive to dupilumab: A single-centre retrospective-cohort study
    Greenzaid, Jonathan D.
    Hrin, Matthew L.
    Feldman, Steven R.
    Strowd, Lindsay C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [33] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [34] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [35] Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study
    Sood, Siddhartha
    Georgakopoulos, Jorge R.
    Maliyar, Khalad
    Sachdeva, Muskaan
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 96 - 97
  • [36] Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
    Gonzalez Mazario, Roxana
    Fragio Gil, Jorge Juan
    Ivorra Cortes, Jose
    Grau Garcia, Elena
    Canada Martinez, Antonio Jose
    Puig, Luis Gonzalez
    Negueroles Albuixech, Rosa Maria
    Roman Ivorra, Jose Andres
    REUMATOLOGIA CLINICA, 2022, 18 (09): : 523 - 530
  • [37] Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience
    Simonetti, O.
    Radi, G.
    Diotallevi, F.
    Molinelli, E.
    Rizzetto, G.
    Offidani, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 939 - 940
  • [38] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
  • [39] Persistence and adherence with dupilumab therapy in patients with atopic dermatitis: a single-centre experience
    Silverberg, J. I.
    Hong, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E78 - E78
  • [40] Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
    Eichenfield, Lawrence F.
    Armstrong, April
    Guttman-Yassky, Emma
    Lio, Peter A.
    Chen, Chi-Chang
    Hines, Dionne M.
    McGuiness, Catherine B.
    Ganguli, Sohini
    Delevry, Dimittri
    Sierka, Debra
    Mallya, Usha G.
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1337 - 1350
12345